If you invested in in
A $1,000 investment in Abbott Laboratories (ABT) in January 2016 would be worth $2,871 as of June 2026 with dividends reinvested — 10.7% a year. Use the dropdowns above to try any amount, ticker, or starting month back to April 1983.
Growth of $1,000 in ABT since January 2016
dividends reinvested · monthlyAbbott Laboratories (ABT). Total return approximated via dividend- and split-adjusted closes (dividends reinvested, no taxes or fees). Not investment advice.
$1,000 invested in ABT, by starting year
| Invested in | Worth today (div. reinvested) | Price-only | Multiple | Annualized |
|---|---|---|---|---|
| 1983 | $132,933 | $68,718 | 133× | 12.0% |
| 1984 | $141,694 | $73,243 | 142× | 12.4% |
| 1985 | $130,819 | $67,625 | 131× | 12.5% |
| 1986 | $89,911 | $46,477 | 89.9× | 11.8% |
| 1987 | $56,838 | $29,383 | 56.8× | 10.8% |
| 1988 | $63,397 | $32,773 | 63.4× | 11.4% |
| 1989 | $63,072 | $32,606 | 63.1× | 11.7% |
| 1990 | $47,547 | $24,580 | 47.5× | 11.2% |
| 1991 | $35,523 | $18,364 | 35.5× | 10.6% |
| 1992 | $24,192 | $12,506 | 24.2× | 9.7% |
| 1993 | $28,096 | $14,524 | 28.1× | 10.5% |
| 1994 | $26,191 | $13,540 | 26.2× | 10.6% |
| 1995 | $21,841 | $11,291 | 21.8× | 10.3% |
| 1996 | $17,897 | $9,398 | 17.9× | 10.0% |
| 1997 | $13,669 | $7,329 | 13.7× | 9.3% |
| 1998 | $10,344 | $5,641 | 10.3× | 8.6% |
| 1999 | $7,777 | $4,301 | 7.8× | 7.8% |
| 2000 | $10,911 | $6,133 | 10.9× | 9.5% |
| 2001 | $7,782 | $4,452 | 7.8× | 8.4% |
| 2002 | $5,951 | $3,461 | 6.0× | 7.6% |
| 2003 | $8,804 | $5,239 | 8.8× | 9.8% |
| 2004 | $7,614 | $4,636 | 7.6× | 9.5% |
| 2005 | $6,652 | $4,150 | 6.7× | 9.3% |
| 2006 | $6,818 | $4,330 | 6.8× | 9.9% |
| 2007 | $5,448 | $3,525 | 5.4× | 9.2% |
| 2008 | $5,022 | $3,326 | 5.0× | 9.2% |
| 2009 | $4,952 | $3,370 | 5.0× | 9.7% |
| 2010 | $5,018 | $3,529 | 5.0× | 10.4% |
| 2011 | $5,681 | $4,137 | 5.7× | 12.0% |
| 2012 | $4,571 | $3,451 | 4.6× | 11.2% |
| 2013 | $3,410 | $2,646 | 3.4× | 9.6% |
| 2014 | $3,097 | $2,445 | 3.1× | 9.6% |
| 2015 | $2,482 | $2,003 | 2.5× | 8.3% |
| 2016 | $2,871 | $2,369 | 2.9× | 10.7% |
| 2017 | $2,538 | $2,146 | 2.5× | 10.5% |
| 2018 | $1,670 | $1,442 | 1.7× | 6.3% |
| 2019 | $1,397 | $1,228 | 1.4× | 4.6% |
| 2020 | $1,151 | $1,029 | 1.2× | 2.2% |
| 2021 | $799 | $725 | 0.8× | -4.1% |
| 2022 | $764 | $703 | 0.8× | -6.0% |
| 2023 | $865 | $811 | 0.9× | -4.2% |
| 2024 | $829 | $792 | 0.8× | -7.7% |
| 2025 | $718 | $701 | 0.7× | -21.6% |
Methodology
Investments are assumed made at the first trading day's close of the chosen year. "Dividends reinvested" uses split- and dividend-adjusted closes (a standard total-return approximation; taxes and fees excluded). "Price-only" uses split-adjusted closes. ABT data begins April 1983; values as of June 2026 and refresh daily. Past performance does not predict future returns; not investment advice.
See the live ABT chart and fundamentals on the ABT quote page or compare with the same investment in SPY.
